These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34918194)

  • 1. Fixed-dose Combination of Metoprolol, Telmisartan, and Chlorthalidone for Essential Hypertension in Adults with Stable Coronary Artery Disease: Phase III Study.
    Sarkar G; Gaikwad VB; Sharma A; Halder SK; Kumar DA; Anand J; Agrawal S; Kumbhar A; Kinholkar B; Mathur R; Doshi M; Bachani D; Mehta S
    Adv Ther; 2022 Feb; 39(2):923-942. PubMed ID: 34918194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy, safety, and tolerability of the FDC of telmisartan + bisoprolol with telmisartan + metoprolol succinate ER combination therapy for stage 1 and stage 2 hypertension: A double-blind, multicentric, phase-III clinical study.
    Wander GS; Ram B; Kumar Sonkar S; Manjunath CN; Kamath P; Sreenivasamurthy L; Balamurugan R; Narasinga Rao S; Roy D; Vipulkumar Bachubhai P; S M; Kumar M K
    Indian Heart J; 2024; 76(3):159-166. PubMed ID: 38871219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study.
    Punzi HA
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.
    Heagerty AM; Mallion JM
    Drugs Aging; 2009; 26(1):61-76. PubMed ID: 19102515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
    Hsueh WA; Shojaee A; Maa JF; Neutel JM
    Curr Med Res Opin; 2012 Nov; 28(11):1809-18. PubMed ID: 23072496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined olmesartan, amlodipine, and hydrochlorothiazide therapy in randomized patients with hypertension: a subgroup analysis of the TRINITY study by age.
    Lewin AJ; Izzo JL; Melino M; Lee J; Fernandez V; Heyrman R
    Drugs Aging; 2013 Jul; 30(7):549-60. PubMed ID: 23549909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Open-label study assessing the long-term efficacy and safety of triple olmesartan/amlodipine/hydrochlorothiazide combination therapy for hypertension.
    Volpe M; de la Sierra A; Ammentorp B; Laeis P
    Adv Ther; 2014 May; 31(5):561-74. PubMed ID: 24760656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, multinational, phase III study.
    Fogari R; Taddei S; Holm-Bentzen M; Baszak J; Melani L; Schumacher K
    Clin Drug Investig; 2010; 30(9):581-97. PubMed ID: 20593911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, non-comparative study to evaluate the efficacy and safety of fixed-dose olmesartan/amlodipine in Korean patients with hypertension who are naïve or non-responders to anti-hypertensive monotherapy (ACE-HY study).
    Jung HW; Kim KI; Park CG; Kang DH; Ahn Y; Bae JH; Kim CH
    Clin Exp Hypertens; 2015; 37(6):482-9. PubMed ID: 25816197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple-Combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study.
    Chrysant SG; Littlejohn T; Izzo JL; Kereiakes DJ; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    Am J Cardiovasc Drugs; 2012 Aug; 12(4):233-43. PubMed ID: 22799613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of an olmesartan medoxomil-based regimen in patients with stage 1 hypertension: a randomized, double-blind, placebo-controlled study.
    Chrysant SG
    Clin Drug Investig; 2010; 30(7):473-82. PubMed ID: 20528002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Tolerability of Telmisartan/Amlodipine + Hydrochlorothiazide Versus Telmisartan/Amlodipine Combination Therapy for Essential Hypertension Uncontrolled With Telmisartan/Amlodipine: The Phase III, Multicenter, Randomized, Double-blind TAHYTI Study.
    Sung KC; Oh YS; Cha DH; Hong SJ; Won KH; Yoo KD; Rha SW; Ahn YK; Ahn JC; Jang JY; Hong TJ; Cho SK; Park SH; Hyon MS; Nam CW; Chae IH; Yoo BS; Song JM; Jeong JO; Yoon YW; Kim BS; Yang TH; Cho DK; Kim SH; Choi YJ; Ahn JH; Jeon DW; Kim HS
    Clin Ther; 2018 Jan; 40(1):50-63.e3. PubMed ID: 29248384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial.
    Jo SH; Park SJ; Kim EJ; Kim SJ; Cho HJ; Song JM; Shin J; Park JJ; Shin JH; Han KR; Choi DJ
    Trials; 2018 Jun; 19(1):324. PubMed ID: 29925421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double-blind, active-controlled, multicenter phase 3 trial.
    Cho EJ; Kim MH; Kim YH; Chang K; Choi DJ; Kang WC; Shin J; Kim SH; Lee N; Son JW; Doh JH; Kim WS; Hong SJ; Rhee MY; Ahn Y; Lim SW; Hong SP; Choi SY; Hyon MS; Hwang JY; Kwon K; Cha KS; Ihm SH; Lee JH; Yoo BS; Kim HS
    J Clin Hypertens (Greenwich); 2023 Sep; 25(9):817-827. PubMed ID: 37614053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of low-dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double-blind, parallel, phase II trial.
    Sung KC; Sung JH; Cho EJ; Ahn JC; Han SH; Kim W; Kim KH; Sohn IS; Shin J; Kim SY; Kim KI; Kang SM; Park SJ; Kim YJ; Shin JH; Park SM; Park CG
    J Clin Hypertens (Greenwich); 2022 Oct; 24(10):1298-1309. PubMed ID: 36094783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of olmesartan medoxomil-amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single-arm, multi-center, real-world study.
    Cui Z; Qiu Z; Cheng W; Hu W; Ma G; Cai X; Jin Y; Zhao Y; He L; Li Y; Bu P; Chen X; Wang R; Chen L; Dong P; Feng L; Han X; Hong M; Hou Y; Liao M; Wang M; Wang X; Xie J; Xu Y; Wang Z; Huang K; Li Y; Li D; Ji X; Huang J; Wang J; Fang D; Wang J; Tang L; Liu Y; Fu G; Du J; Wang L; Liu M; Ge J
    J Clin Hypertens (Greenwich); 2024 Jan; 26(1):5-16. PubMed ID: 37667532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Volpe M; Brommer P; Haag U; Miele C
    Clin Drug Investig; 2009; 29(1):11-25. PubMed ID: 19067471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fixed dose combinations of metoprolol and amlodipine in essential hypertension: MARS--a randomized controlled trial.
    Devi P; Xavier D; Sigamani A; Pandey S; Thomas T; Murthy S; Sharma K; Bosco B; Mehta K; Joshi S; Gupta R; Singh G; Hiremath J; Ds C; Nambiar A; Pais P
    Blood Press Suppl; 2011 Dec; 2():5-12. PubMed ID: 22352120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication.
    Neldam S; Edwards C
    Expert Opin Pharmacother; 2009 Feb; 10(3):345-52. PubMed ID: 19191674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.